Partnerships

Partnerships

How we can help

Every discovery program is different.

Rather than offering a one-size-fits-all platform, NOVA provides a continuously improving discovery engine that can be configured around your therapeutic targets, biological modalities, and research objectives.

Whether you're exploring a new target, evaluating computational strategies, or designing an entirely new discovery workflow, we build collaborations around the scientific question—not a predefined product.

We are open to partnering with biotech, pharmaceutical, and research organizations to collaborate beyond traditional service agreements.

An intelligent path to drug candidates

1

screening as a service

Submit a target. NOVA's network generates and ranks lists — across small molecules or nanobodies — giving you the starting points for your discovery program without building the infrastructure yourself.

1

screening as a service

Submit a target. NOVA's network generates and ranks lists — across small molecules or nanobodies — giving you the starting points for your discovery program without building the infrastructure yourself.

2

co-development opportunities

Bring your biology, your data, and/or your domain expertise. We bring the network. Together we can design a program around shared goals and shape what comes out of it.

2

co-development opportunities

Bring your biology, your data, and/or your domain expertise. We bring the network. Together we can design a program around shared goals and shape what comes out of it.

3

custom tools + competitions

Some scientific problems require new infrastructure rather than existing tools. We've built new capabilities for partners, and we're open to explore new approaches where they create meaningful scientific value.

3

custom tools + competitions

Some scientific problems require new infrastructure rather than existing tools. We've built new capabilities for partners, and we're open to explore new approaches where they create meaningful scientific value.

Collaborations
driving real-world results

Current partnerships

OnePot.AI

OnePot.AI built the AI-driven robotic synthesis lab on the other side of our screening pipeline. Hits identified through Nova can now be syntehsized in days, not months — closing the loop between virtual screening and real-world chemistry.

Robotics

Synthesis

Wet Lab Validation

Current partnerships

OnePot.AI

OnePot.AI built the AI-driven robotic synthesis lab on the other side of our screening pipeline. Hits identified through Nova can now be syntehsized in days, not months — closing the loop between virtual screening and real-world chemistry.

Robotics

Synthesis

Wet Lab Validation

Current partnerships

Yalotein

Yalotein's nanobody programs needed a screening track that didn't exist yet. We built it — a purpose-built competition for nanobodies, now live on the network and open to all.

Nanobodies

Screening

Wet Lab Validation

Current partnerships

Yalotein

Yalotein's nanobody programs needed a screening track that didn't exist yet. We built it — a purpose-built competition for nanobodies, now live on the network and open to all.

Nanobodies

Screening

Wet Lab Validation

Current partnerships

Diagen AI

Together we’re building a Hit-picking tool for large compound libraries. This will help automate the highly manual molecule selection process.

Hit-Picking

Compound libraries

Current partnerships

Diagen AI

Together we’re building a Hit-picking tool for large compound libraries. This will help automate the highly manual molecule selection process.

Hit-Picking

Compound libraries

Contact us

powering biomedical innovation

Whether you're exploring a new target, expanding your screening pipeline, or looking to leverage decentralized AI for drug discovery.